Biotech
$200 Million, $1.2 Billion Valuation, Zero Dogs: Inside Warhound's Gene-Edited War Dog Bet
Warhound launched with $200M in seed funding at a $1.2B valuation to clone and gene-edit US military working dogs, with first pups due in early 2027.
Topic
Defense
The latest Defense news and analysis from Tech Arcade.